This is a summary. To read the whole story subscribe to BostonGlobe.com
WASHINGTON — In just one Cape Cod community, the toll is numbingly familiar. A father and son steal 18,000 opiate pills from a pharmacy. A grandfather discovers his 22-year-old grandson passed out with a syringe in his arm. The deputy police chief’s own nephew becomes addicted to oxycodone. The pharmaceutical industry has developed pills that are strongly resistant to being crushed — and are therefore difficult for addicts to abuse — but industry profit margins and a ponderous federal bureaucracy have kept them from widespread adoption in the market.